Association of British Neurologists: Audit of Sodium Valproate in Women of Childbearing potential

Information for each neurologist to send to the ABN

Part B. Following the audit using the tool in part A, please use this form to summarise the findings and submit to the ABN
For each option please enter a percentage totaling to 100%
1. Of the women of childbearing potential, you see who take Valproate, what proportion take this for(Required.)
Other
2. In what proportion of women of childbearing potential you see who are taking Valproate was there documentation in the notes/clinic letters that the woman has been informed about the teratogenic risks of VPA and that the info leaflet has been shared as per MHRA requirements?(Required.)
3. In what proportion of women of childbearing potential taking Valproate was there documentation in notes/clinic letter that the woman has been informed about the need to be on highly effective contraception or that the need for highly effective contraception is not deemed appropriate?(Required.)
4. In what proportion of women of childbearing potential taking Valproate was there a signed Annual Risk Acknowledgement form in the notes and evidence sent to GP/patient?(Required.)
5. How many women were included in the survey?(Required.)
Optional Questions
6A. Data submitted is from
6B. Data submitted is from
6C. Data submitted is from
Please enter your email address if you wish to receive a confirmation email.